Investigation of the Safety and Effectiveness of Monofocal Toric Intraocular Lens (IOL)

NCT06399211 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 261

Last updated 2026-04-22

Study results available
· View outcomes & findings →

Summary

This study is a prospective, multicenter, randomized, double masked trial comparing an investigational Monofocal Toric intraocular lens (IOL) (PODEYE TORIC CYL 1.5 D) and a commercially available non-toric monofocal IOL.

Conditions

  • Eye Diseases
  • Postcataract Aphakia
  • Cataract
  • Lens Opacities
  • Astigmatism

Interventions

DEVICE

PODEYE TORIC Monofocal IOL

Cataractous lens will be removed in the study eyes and the PODEYE TORIC IOL (1.5 D) will be implanted in the capsular bag.

DEVICE

Alcon AcrySof SA60AT Monofocal IOL

Cataractous lens will be removed in the study eyes and the Alcon AcrySof SA60AT Monofocal IOL will be implanted in the capsular bag.

Sponsors & Collaborators

  • Beaver-Visitec International, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-28
Primary Completion
2025-11-06
Completion
2025-11-06

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06399211 on ClinicalTrials.gov